Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a Phase 1/2 study to evaluate safety, tolerability, and efficacy of BBM-D101 in Duchenne muscular dystrophy. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• BBM-D101

Snippet

Sponsor: Belief BioMed (Beijing) Co., Ltd | Conditions: DMD | Phase 1, Phase 2 | Status: RECRUITING